Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

211 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Autologous peripheral blood stem cells (PBSC) in breast cancer.
Patrone F, Valbonesi M, Ballestrero A. Patrone F, et al. Among authors: ballestrero a. Transfus Apher Sci. 2002 Oct;27(2):167-73. doi: 10.1016/s1473-0502(02)00039-3. Transfus Apher Sci. 2002. PMID: 12350052 Review. No abstract available.
Dose-dense vinorelbine and paclitaxel with granulocyte colony-stimulating factor in metastatic breast cancer patients: anti-tumor activity and peripheral blood progenitor cell mobilization capability.
Ballestrero A, Montemurro F, Gonella R, Capaldi A, Danova M, Friedman D, Puglisi M, Aglietta M, Patrone F. Ballestrero A, et al. Breast Cancer Res Treat. 2003 Dec;82(3):185-90. doi: 10.1023/B:BREA.0000004374.72658.17. Breast Cancer Res Treat. 2003. PMID: 14703065 Clinical Trial.
Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF.
Ballestrero A, Ferrando F, Garuti A, Basta P, Gonella R, Stura P, Mela GS, Sessarego M, Gobbi M, Patrone F. Ballestrero A, et al. J Clin Oncol. 1999 Apr;17(4):1296. doi: 10.1200/JCO.1999.17.4.1296. J Clin Oncol. 1999. PMID: 10561192 Clinical Trial.
Kinase domain mutations of BCR-ABL identified at diagnosis before imatinib-based therapy are associated with progression in patients with high Sokal risk chronic phase chronic myeloid leukemia.
Carella AM, Garuti A, Cirmena G, Catania G, Rocco I, Palermo C, Pica G, Pierri I, Miglino M, Ballestrero A, Gobbi M, Patrone F. Carella AM, et al. Among authors: ballestrero a. Leuk Lymphoma. 2010 Feb;51(2):275-8. doi: 10.3109/10428190903503446. Leuk Lymphoma. 2010. PMID: 20038234
The use of dendritic cells in cancer immunotherapy.
Nencioni A, Grünebach F, Schmidt SM, Müller MR, Boy D, Patrone F, Ballestrero A, Brossart P. Nencioni A, et al. Among authors: ballestrero a. Crit Rev Oncol Hematol. 2008 Mar;65(3):191-9. doi: 10.1016/j.critrevonc.2007.10.002. Epub 2007 Dec 4. Crit Rev Oncol Hematol. 2008. PMID: 18055210 Review.
211 results